| The characterisation of subjective cognitive decline F Jessen, RE Amariglio, RF Buckley, WM van der Flier, Y Han, ... The Lancet Neurology 19 (3), 271-278, 2020 | 942 | 2020 |
| Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study BJ Hanseeuw, RA Betensky, HIL Jacobs, AP Schultz, J Sepulcre, ... JAMA neurology 76 (8), 915-924, 2019 | 695 | 2019 |
| Implementation of subjective cognitive decline criteria in research studies JL Molinuevo, LA Rabin, R Amariglio, R Buckley, B Dubois, KA Ellis, ... Alzheimer's & Dementia 13 (3), 296-311, 2017 | 512 | 2017 |
| Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures used Across 19 International Research Studies LA Rabin, CM Smart, PK Crane, RE Amariglio, LM Berman, M Boada, ... Journal of Alzheimer's disease, 2015 | 464 | 2015 |
| Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ... Alzheimer's & Dementia 15 (3), 465-476, 2019 | 360 | 2019 |
| Phases of hyperconnectivity and hypoconnectivity in the default mode and salience networks track with amyloid and tau in clinically normal individuals AP Schultz, JP Chhatwal, T Hedden, EC Mormino, BJ Hanseeuw, ... Journal of Neuroscience 37 (16), 4323-4331, 2017 | 266 | 2017 |
| Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults RF Buckley, EC Mormino, JS Rabin, TJ Hohman, S Landau, ... JAMA neurology 76 (5), 542-551, 2019 | 262 | 2019 |
| The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals RA Sperling, EC Mormino, AP Schultz, RA Betensky, KV Papp, ... Annals of neurology 85 (2), 181-193, 2019 | 235 | 2019 |
| 2022 Alzheimer's disease facts and figures J Gaugler, B James, T Johnson, J Reimer, M Solis, J Weuve, RF Buckley, ... Alzheimers & Dementia 18 (4), 700-789, 2022 | 227 | 2022 |
| Interactive associations of vascular risk and β-amyloid burden with cognitive decline in clinically normal elderly individuals: findings from the Harvard Aging Brain Study JS Rabin, AP Schultz, T Hedden, A Viswanathan, GA Marshall, ... JAMA neurology 75 (9), 1124-1131, 2018 | 213 | 2018 |
| Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease RF Buckley, P Maruff, D Ames, P Bourgeat, RN Martins, CL Masters, ... Alzheimer's & Dementia 12 (7), 796-804, 2016 | 211 | 2016 |
| Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts RF Buckley, EC Mormino, RE Amariglio, MJ Properzi, JS Rabin, YY Lim, ... Alzheimer's & Dementia 14 (9), 1193-1203, 2018 | 209 | 2018 |
| Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age R Buckley, MM Saling, D Ames, CC Rowe, NT Lautenschlager, ... International Psychogeriatrics 25 (8), 1307-1315, 2013 | 201 | 2013 |
| Region-specific association of subjective cognitive decline with tauopathy independent of global β-amyloid burden RF Buckley, B Hanseeuw, AP Schultz, P Vannini, SL Aghjayan, ... JAMA neurology 74 (12), 1455-1463, 2017 | 172 | 2017 |
| Non-pharmacologic interventions for older adults with subjective cognitive decline: systematic review, meta-analysis, and preliminary recommendations CM Smart, JE Karr, CN Areshenkoff, LA Rabin, C Hudon, N Gates, JI Ali, ... Neuropsychology review 27, 245-257, 2017 | 143 | 2017 |
| Associations of physical activity and β-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults JS Rabin, H Klein, DR Kirn, AP Schultz, HS Yang, O Hampton, S Jiang, ... JAMA neurology 76 (10), 1203-1210, 2019 | 133 | 2019 |
| PET staging of amyloidosis using striatum BJ Hanseeuw, RA Betensky, EC Mormino, AP Schultz, J Sepulcre, ... Alzheimer's & Dementia 14 (10), 1281-1292, 2018 | 114 | 2018 |
| Functional network integrity presages cognitive decline in preclinical Alzheimer disease RF Buckley, AP Schultz, T Hedden, KV Papp, BJ Hanseeuw, G Marshall, ... Neurology 89 (1), 29-37, 2017 | 113 | 2017 |
| Segmentation of the mouse hippocampal formation in magnetic resonance images K Richards, C Watson, RF Buckley, ND Kurniawan, Z Yang, MD Keller, ... Neuroimage 58 (3), 732-740, 2011 | 111 | 2011 |
| Genetic variants and functional pathways associated with resilience to Alzheimer’s disease L Dumitrescu, ER Mahoney, S Mukherjee, ML Lee, WS Bush, ... Brain 143 (8), 2561-2575, 2020 | 106 | 2020 |
Reisa SperlingProfessor of Neurology, Harvard Medical School, Brigham and Women's Hospital, Massachusetts General Hospital確認したメール アドレス: rics.bwh.harvard.edu
